Analysis

As Featured In

Bespoke Sector Analysis

June 26, 2020
Assessment of COVID-19 Hiring Strategy May 2020
June 26, 2020
Evolution Briefing: Cambrex Announce New CEO
June 26, 2020
UK COVID -19 Vaccine activity
June 16, 2020
Evolution Insights: The Race for a COVID -19 Vaccine
June 9, 2020
Lonza accelerating efforts to make Moderna vaccine
June 9, 2020
COVID Drug Strategies
June 5, 2020
Evolution Insight: Pfizer and BioNtech: a lightspeed deal for potential Covid Vaccine.
June 5, 2020
Evolution Briefing: Lonza announce new CEO
May 6, 2020
Moderna and Lonza Announce Worldwide Collaboration to Manufacture vaccine against COVID-19
February 4, 2019
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
October 24, 2018
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam's Thirty Year Journey to First Approval
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
October 10, 2018
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX



Contact Us